1. Lipids (Lipid Profile)

2. Introduction The major lipids present in the plasma are:
fatty acids,
Triglycerides,
cholesterol
and phospholipids.
Other lipid-soluble substances, present in much smaller amounts (e.g. steroid hormones ).
Elevated plasma concentrations of lipids, particularly cholesterol, are related to the pathogenesis of atherosclerosis.

3. Lipids transport
Lipids are carried in the bloodstream by complexes known as lipoproteins.
This is because these lipids are not soluble in the plasma water.
Thus they travel in micelle-like complexes composed of phospholipids, cholesterol and protein on the outside with cholesteryl esters, and triglycerides on the inside.
The four main types of lipoproteins are chylomicrons, VLDL, LDL, and HDL

4. Clinical Significance
Cholesterol and triglycerides, like many other essential components of the body, attract clinical attention when present in abnormal concentrations.
Increased or decreased levels usually occur because of abnormalities in the synthesis, degradation, and transport of their associated lipoprotein particles.
Increased or decreased plasma lipoproteins are named hyperlipoproteinemia & hypolipoproteinemia respectively.

5. Early and late atherosclerotic lesions
Fatty streak
Thrombotic athero lesion, myocardial infarct

6. Generic Lipoprotein

7. Metabolic Syndrome: Disease of the Modern Era
Constellation of several risk factors that increase chance of coronary artery disease, peripheral vascular disease, stroke and type 2 diabetes.
Combination of 3 or more of the following risks:
• Abdominal obesity
• Triglyceride levels above 150 mg/dL
• Low HDL cholesterol
• Elevated blood pressure (>130/85 mm Hg)
• Fasting blood glucose > 100 mg/dL
Aging a major contributor: prevalence in yr olds = 6.7%; yr olds = 43.5%

8. CM Major apoB apoB apoB apoB apoA-I Protein Major TG TG CE CE CE Lipid
Lipoprotein Nomenclature and Composition CM
VLDL
IDL
LDL
HDL
Major apoB apoB apoB apoB apoA-I
Protein
Major TG TG CE CE CE
Lipid
CM= chylomicron TG=triglyceride
VLDL= very low density lipoprotein CE= cholesteryl ester
IDL= intermediate density lipoprotein
LDL= low density lipoprotein
HDL= high density lipoprotein
Apo = apolipoprotein

9. Site of Synthesis of Lipoproteins
Nascent-HDL
apoA-I
Liver
VLDL
apoB-100
apoCs
apoE
IDL
LDL
apoB-48 CM
Intestine

10. Lipids as Biochemical Markers of Disease
Clinical chemistry laboratories offer many tests for lipid disorders.
One of the most common tests is the lipid profile.
This panel of tests includes measurement of triglycerides and cholesterol in the form of lipoprotein-cholesterol molecules,
low density lipoprotein cholesterol (LDL-C)
and high-density lipoprotein cholesterol (HDL-C).
The results of testing for these lipids provide measures of risk for coronary artery disease.

11. It is therefore clear that lipid measurements should be made in all patients known to have vascular disease, and in those at increased risk.
Thus plasma lipids should be measured in the individuals with the following:
CHD (and cerebrovascular and peripheral vascular disease)
a family history of premature coronary disease (occurring at age <60 years)
other major risk factors for CHD (e.g. diabetes mellitus, hypertension)
patients with clinical features of hyperlipidaemia
patients whose plasma is seen to be lipaemic.

12. Positive and Negative Risk Factors in Atherosclerosis
Positive Negative
Age: Males > 45 years Elevated HDL cholesterol
Females > 55 years Low LDL cholesterol
Family history of early CHD Good genes
Elevated LDL cholesterol (>130 mg/dL) Female gender (estrogen)
Elevated triglyceride (>150 mg/dL) Exercise
Diabetes mellitus
Hypertension
Obesity
Smoking
CHD, coronary heart disease

13. Triglycerides Sources of Triglycerides:
Glycerol backbone with FA attached by ester bonds
Sources of Triglycerides:
Exogenous source: Dietary
Endogenous : Liver and tissue storage
Glycerol
Triglyceride

14. Triglycerides
Serum triglycerides measurements are done for the following clinical reasons:
• Hypertriglyceridemia increases the risk for pancreatitis.
• Hypertriglyceridemia is associated with the following clinical findings: eruptive xanthoma, lipemia retinalis, hepatomegaly, splenomegaly, depressed HDL-cholesterol.
in characterizing risk of CVDs
• For the estimation of LDL-cholesterol, using the Friedewald equation
lipemia retinalis: that manifested by a milky appearance of the veins and arteries of the retina.
Eruptive xanthoma: The sudden eruption on the skin of crops of pink papules (firm pea-sized bumps) with a creamy center. They may appear on the hands, feet, arms, legs and buttocks.

15. Enzymatic Method
Glycerol, released from triglycerides after hydrolysis with lipoprotein lipase,
Tranformed by glycerolkinase into glycerol-3- phosphate
which is oxidized by glycerolphosphate oxidase into dihydroxyacetone phosphate and hydrogen peroxide.
In the presence of peroxidase, the hydrogen peroxide oxidizes the chromogen 4- aminophenazone/ESPT to form purple quinoneimine whose intensity is proportional to the concentration of triglycerides in the sample.

16. glycerolphosphate oxidase
Enzymatic Method
Triglycerides Glycerol + 3 fatty acids
Glycerol + ATP Glycerol-3 phosphate + ADP
Glycerol-3 phosphate dihydroxyacetone + H2O phosphate
H2O2 + 4-aminophenazone/ESPT Quinoneimine
Lipoprotein lipase
glycerolkinase
glycerolphosphate oxidase
peroxidase

17. Cholesterol
Cholesterol is a sterol compound that is found in all animal tissues
Serves many important physiological functions including:
synthesis of bile acids,
steroid hormones,
and cell membranes.
Cholesterol also appears to be involved in atherosclerosis; thus cholesterol measurement is one of the most common laboratory tests used today.

18. Enzymatic Reaction
Determination of cholesterol after enzymatic hydrolysis and oxidation.
The colorimetric indicator is quinoneimine which is generated from 4-aminoantipyrine and hydroxybenzoate by hydrogen peroxide under the catalytic action of peroxidase
Cholesterol Esterase
Cholesterol oxidase
Cholesterol-3-one
Peroxidase

19. HDL HDL is a fraction of plasma lipoproteins It is composed of:
25% phospholipid,
20% cholesterol,
and 5% triglycerides
Evidence suggests that high-density lipoprotein (HDL) cholesterol is a primary coronary heart disease (CHD) risk factor.

20. Analysis Methods Ultracentrifugation
Polyacrylamide Gel Electrophoresis
Precipitation
based on the ability of various agents to precipitate selectively the major lipoprotein fractions, except HDL
Immunological
Antibodies against human lipoproteins are used to form antigen-antibody complexes with LDL, VLDL and chylomicrons in a way that only HDL-cholesterol is selectively determined by an enzymatic cholesterol measurement

21. Precipitation Method
In the plasma, cholesterol is transported by three lipoproteins: high density lipoprotein, low density lipoprotein, and very low density lipoprotein
HDL lipoproteins are assayed, after precipitation of LDL and VLDL lipoproteins with polyethylene glycol (PEG) 6000.
HDL is left in the supernatant solution for cholesterol quantitation.

22. Low Density Lipoprotein
[LDL-chol] = [Total chol] - [HDL-chol] - ([TG]/2.2)
Where all concentrations are given in mmol/L
(note that if calculated using all concentrations in mg/dL then the equation is:
[LDL-chol] = [Total chol] - [HDL-chol] - ([TG]/5)
The quotient ([TG]/5) is used as an estimate of VLDL- cholesterol concentration.
It assumes, first, that virtually all of the plasma TG is carried on VLDL, and second, that the TG:cholesterol ratio of VLDL is constant at about 5:1

23. Limitations of the Friedewald equation
The Friedewald equation should not be used under the following circumstances:
when chylomicrons are present
when plasma triglyceride concentration exceeds 400 mg/dL
in patients with dysbetalipoproteinemia (type III hyperlipoproteinemia